@article{f753b51204304ec1a5a69810c3826e11,
title = "The search for surrogate endpoints in trials in diffuse large B-cell lymphoma: The surrogate endpoints for aggressive lymphoma project",
keywords = "Biomarkers, Clinical trials, Diffuse large B-cell lymphoma, Individual patient data, Meta-database, Surrogate endpoints",
author = "Sargent, {Daniel J.} and Qian Shi and Flowers, {Christopher R.} and Norbert Schmitz and Habermann, {Thomas M.} and Jocelyne Flament and Tommy Fu and Bertrand Coiffier",
note = "Funding Information: We would like to thank Celgene Corporation for sponsoring the study. Editorial support for this manuscript was provided by Bio Connections LLC, which was funded by Celgene Corporation. The SEAL group (in alphabetical order) consists of the following members: Bertrand Coiffier, David Cunningham, Jocelyne Fla-ment, Christopher R. Flowers, Tommy Fu, Herve Ghesquieres, Thomas M. Habermann, Corinne Haioun, Raoul Herbrecht, Ulrich Jaeger, Matthew J. Maurer, Francesco Merli, Tina Nielsen, Fang-Shu Ou, Michael Pfreundschuh, Daniel J. Sargent, Norbert Schmitz, John F. Seymour, Qian Shi, Herv{\'e} Tilly, Lixia Wang, and Marita Ziepert.",
year = "2017",
month = dec,
doi = "10.1634/theoncologist.2017-0177",
language = "English (US)",
volume = "22",
pages = "1415--1418",
journal = "Oncologist",
issn = "1083-7159",
publisher = "AlphaMed Press",
number = "12",
}